NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank673Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth140ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration846EPS acceleration at or above zero, largest first.
- High return on equity380ROE at least 25%, highest first.
- NYSE only366The same ranking with NYSE listings only.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| CRBPCorbus Pharmaceuticals Holdings, Inc.NASDAQ | — | — | — | -99.7% | — | 2026-06-30Filed 2026-08-06 |
| CRBUCaribou Biosciences, Inc.NASDAQ | — | — | -43.8% | -105.4% | -1030.4% | 2026-06-30Filed 2026-08-13 |
| CRCLCircle Internet Group, Inc.NYSE | — | — | 41.1% | 12.9% | 321.1% | 2026-06-30Filed 2026-08-05 |
| CRD-ACRAWFORD & CONYSE | — | — | -1.4% | 12.6% | 1.8% | 2026-06-30Filed 2026-08-03 |
| CRDFCardiff Oncology, Inc.NASDAQ | — | — | -14.0% | -151.0% | -7884.1% | 2026-06-30Filed 2026-08-11 |
| CRDOCredo Technology Group Holding LtdNASDAQ | — | — | 114.7% | 19.7% | 33.8% | 2026-08-01Filed 2026-09-02 |
| CREXCREATIVE REALITIES, INC.NASDAQ | — | — | — | -110.6% | — | 2026-06-30Filed 2026-08-14 |
| CRGYCrescent Energy CoNYSE | — | — | 55.3% | 1.1% | 1.3% | 2026-06-30Filed 2026-08-03 |
| CRISCURIS INCNASDAQ | — | — | -100.0% | -450.5% | -490.3% | 2026-06-30Filed 2026-08-14 |
| CRKCOMSTOCK RESOURCES INCNYSE | — | — | -24.9% | 19.7% | 23.3% | 2026-06-30Filed 2026-07-30 |
| CRMTAMERICAS CARMART INCNASDAQ | — | — | -67.5% | — | — | 2026-07-31Filed 2026-09-09 |
| CRNCCerence Inc.NASDAQ | — | — | 11.8% | -9.3% | -5.0% | 2026-06-30Filed 2026-08-06 |
| CRONCronos Group Inc.NASDAQ | — | — | 58.4% | 6.5% | 39.1% | 2026-06-30Filed 2026-08-06 |
| CROXCrocs, Inc.NASDAQ | — | — | 4.6% | 49.4% | 16.2% | 2026-09-30Filed 2026-10-29 |
| CRSPCRISPR Therapeutics AGNASDAQ | — | — | 1041.4% | -25.8% | -3368.7% | 2026-06-30Filed 2026-08-03 |
| CRSRCorsair Gaming, Inc.NASDAQ | — | — | -1.8% | 5.5% | 2.5% | 2026-06-30Filed 2026-08-06 |
| CRTOCriteo S.A.NASDAQ | — | 33.7 pp | -11.3% | — | — | 2026-06-30Filed 2026-08-05 |
| CRUSCIRRUS LOGIC, INC.NASDAQ | — | — | 12.9% | 19.7% | 21.0% | 2026-06-27Filed 2026-08-05 |
| CRVLCORVEL CORPNASDAQ | — | — | 10.7% | 28.2% | 11.7% | 2026-06-30Filed 2026-08-06 |
| CRVOCervoMed Inc.NASDAQ | — | — | -100.0% | -132.2% | -9160.9% | 2026-06-30Filed 2026-08-07 |
| CRVSCorvus Pharmaceuticals, Inc.NASDAQ | — | — | — | -24.0% | — | 2026-06-30Filed 2026-08-06 |
| CRWDCrowdStrike Holdings, Inc.NASDAQ | — | — | — | 1.1% | — | 2026-07-31Filed 2026-08-27 |
| CRWSCROWN CRAFTS INCNASDAQ | — | — | — | 12.5% | — | 2026-06-28Filed 2026-08-12 |
| CRWVCoreWeave, Inc.NASDAQ | — | — | 112.5% | -38.4% | -25.4% | 2026-06-30Filed 2026-08-12 |
| CSAICLOUDASTRUCTURE, INC.NASDAQ | — | — | 13.5% | -239.0% | -145.2% | 2026-06-30Filed 2026-08-18 |
| CSBRCHAMPIONS ONCOLOGY, INC.NASDAQ | — | — | 8.8% | -28.4% | -1.8% | 2026-07-31Filed 2026-09-11 |
| CSCOCISCO SYSTEMS, INC.NASDAQ | — | — | 17.6% | 26.4% | 21.0% | 2026-07-25Filed 2026-09-02 |
| CSGPCOSTAR GROUP, INC.NASDAQ | — | — | 14.1% | 2.2% | 4.9% | 2026-09-30Filed 2026-10-28 |
| CSPICSP INC /MA/NASDAQ | — | — | -6.8% | -1.5% | -1.2% | 2026-06-30Filed 2026-08-14 |
| CSQRCsquare, Inc.NYSE | — | — | 1.4% | — | — | 2026-06-30Filed 2026-08-10 |
| CSRCENTERSPACENYSE | — | — | -4.0% | 3.2% | 8.0% | 2026-06-30Filed 2026-08-03 |
| CSTLCASTLE BIOSCIENCES INCNASDAQ | — | — | 20.1% | -4.1% | -5.4% | 2026-06-30Filed 2026-07-30 |
| CSWCCAPITAL SOUTHWEST CORPNASDAQ | — | — | — | 10.5% | — | 2026-06-30Filed 2026-08-03 |
| CTAAClearthink 1 Acquisition Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-17 |
| CTASCINTAS CORPNASDAQ | — | — | 10.9% | 39.6% | 17.8% | 2026-08-31Filed 2026-10-07 |
| CTEVClaritev CorpNYSE | — | — | 6.6% | — | -28.5% | 2026-06-30Filed 2026-08-07 |
| CTGOContango Silver & Gold Inc.NYSE | — | — | — | -11.8% | — | 2026-06-30Filed 2026-08-13 |
| CTKBCytek Biosciences, Inc.NASDAQ | — | — | 5.6% | — | — | 2026-06-30Filed 2026-08-05 |
| CTMCastellum, Inc.NYSE | — | — | -1.1% | -6.4% | -4.1% | 2026-06-30Filed 2026-08-06 |
| CTMXCytomX Therapeutics, Inc.NASDAQ | — | — | -92.4% | -26.4% | -435.2% | 2026-06-30Filed 2026-08-06 |
| CTNMContineum Therapeutics, Inc.NASDAQ | — | — | — | -24.0% | — | 2026-06-30Filed 2026-07-30 |
| CTNTCHEETAH NET SUPPLY CHAIN SERVICE INC.NASDAQ | — | — | 145.4% | -3.6% | -206.8% | 2026-06-30Filed 2026-08-13 |
| CTOCTO Realty Growth, Inc.NYSE | — | — | 24.3% | 6.5% | 26.1% | 2026-09-30Filed 2026-10-27 |
| CTORCITIUS ONCOLOGY, INC.NASDAQ | — | — | — | -114.1% | — | 2026-06-30Filed 2026-08-14 |
| CTOSCustom Truck One Source, Inc.NYSE | — | — | -2.9% | 3.6% | 2.0% | 2026-09-30Filed 2026-10-26 |
| CTRICenturi Holdings, Inc.NYSE | — | — | 32.9% | 3.3% | 0.9% | 2026-06-28Filed 2026-08-04 |
| CTRNCiti Trends IncNASDAQ | — | -851.2 pp | 10.9% | — | — | 2026-08-01Filed 2026-09-09 |
| CTSOCytosorbents CorpNASDAQ | — | — | 0.2% | — | — | 2026-06-30Filed 2026-08-06 |
| CTWOCOTWO ADVISORS PHYSICAL EUROPEAN CARBON ALLOWANCE TRUSTNYSE | — | — | — | — | — | 2026-08-31Filed 2026-10-09 |
| CTXRCitius Pharmaceuticals, Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-14 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.